Bluepoint Laboratories Inc

FDA Filings

This page includes the latest FDA filings for Bluepoint Laboratories Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
Labetalol Hydrochloride BluePoint Laboratories Inc., Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited	Prescription Medication	2023-07-06
Labetalol Hydrochloride BluePoint Laboratories Inc., Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited	Prescription Medication	2022-07-16
Labetalol Hydrochloride BluePoint Laboratories Inc., Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited	Prescription Medication	2019-02-20
NDC 68001-383 BluePoint Laboratories Inc.	Labetalol Hydrochloride	2019-02-18
NDC 68001-382 BluePoint Laboratories Inc.	Labetalol Hydrochloride	2019-02-18
NDC 68001-381 BluePoint Laboratories Inc.	Labetalol Hydrochloride	2019-02-18

Similar & Related FDA Registered Companies

• Zydus Pharmaceuticals (USA) Inc.
• Cadila Healthcare Limited